Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
23.70
-0.70 (-2.87%)
At close: Mar 10, 2026
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 11.15 billion as of March 10, 2026.
Market Cap
11.15B
Enterprise Value
10.40B
Revenue
61.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 11.15B, a decrease of -57.38%. That is a compound annual growth rate of -78.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.05B | -21.08% |
| Dec 31, 2025 | 14.00B | -46.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 12.12B |
| Everest Medicines | 12.58B |
| Shanghai Haohai Biological Technology | 9.81B |
| HBM Holdings | 9.62B |
| CStone Pharmaceuticals | 9.54B |
| Keymed Biosciences | 15.05B |
| Lepu Biopharma | 8.03B |
| Abbisko Cayman | 7.98B |